MUMBAI, India, March 13 -- Intellectual Property India has published a patent application (202621000194 A) filed by Dr. Rajesh Hadia; Dr. Nisheet Patel; Dr. Hemraj Singh Rajput; Dr. Sarvajeet Khare; Dr. Vishal Singh; and Dr. Nidhi Solanki, Vadodara, Gujarat, on Jan. 2, for 'a method for assessing prevalence of sexual side effects in female psychiatric patients receiving psychotropic medications.'
Inventor(s) include Dr. Rajesh Hadia; Dr. Nisheet Patel; Dr. Hemraj Singh Rajput; Dr. Sarvajeet Khare; Dr. Vishal Singh; and Dr. Nidhi Solanki.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a standardized method for assessing the prevalence of sexual side effects induced by psychotropic medications in female psychiatric patients. The method utilizes a validated Female Sexual Function Index questionnaire combined with demographic, clinical, and therapeutic parameters to identify and quantify sexual dysfunction across multiple domains. The invention enables systematic evaluation of underreported adverse effects, supports evidence-based psychiatric care, and improves patient quality of life."
Disclaimer: Curated by HT Syndication.
